SCHEMBL9890534

SCHEMBL9890534

c1ccc(-c2cc(-c3ccc4oc5ccc6oc7ccc(-n8c9ccccc9c9ccccc98)cc7c6c5c4c3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.40
KMT2A Q03164 8/20 0.40
MEN1 O00255 7/20 0.40
HPGD P15428 7/20 0.40
ALDH1A1 P00352 7/20 0.40
NTSR1 P30989 1/20 0.40
KDM4E B2RXH2 6/20 0.39
LMNA P02545 3/20 0.39
GLA P06280 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 1/20 0.36
MAPK1 P28482 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
NPSR1 Q6W5P4 3/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14867924 0.93 KMT2A (0.40) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL9890099 0.93 KMT2A (0.40) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL22078430 0.93 ATM (0.39) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL14770738 0.93 KMT2A (0.40) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL9890345 0.92 MAPT (0.39) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL9890410 0.92 ALDH1A1 (0.35) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL14867920 0.91 MAPT (0.38) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL9881140 0.90 KMT2A (0.39) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL17899162 0.89 MAPT (0.40) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL16185396 0.89 MAPT (0.40) MAPTKMT2AMEN1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 MAPT 1303/4885KMT2A 842/4885MEN1 1530/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 MAPT 1303/4885KMT2A 842/4885MEN1 1530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.